DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tesofensine is an investigational drug.
There have been 11 clinical trials for Tesofensine. The most recent clinical trial was a Phase 2 trial, which was initiated on March 30th 2017.
The most common disease conditions in clinical trials are Obesity, Prader-Willi Syndrome, and Alzheimer Disease. The leading clinical trial sponsors are Saniona, NeuroSearch A/S, and Boehringer Ingelheim.
Recent Clinical Trials for Tesofensine
|48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)||Saniona||Phase 2|
|A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate||Saniona||Phase 1|
|Study to Investigate the Pharmacokinetic Profile||Saniona||Phase 1|